ABC Transporter Expression: Clues into Chemoresistance of Triple Negative Breast Cancers | Caris Life Sciences
Home / Research / Publications / ABC Transporter Expression: Clues into Chemoresistance of Triple Negative Breast Cancers

Publications

ABC Transporter Expression: Clues into Chemoresistance of Triple Negative Breast Cancers

Background

Triple-negative breast cancer (TNBC) is an aggressive histological subtype with high rates of recurrence and metastatic disease. Intrinsic or acquired multidrug resistance facilitated by the over-expression of drug efflux pumps (ABC transporters: BCRP [ABCG2], MRP1 [ABCC1] and PGP [ABCB1]), may contribute to the aggressive nature of this disease. We examined the expression patterns of drug efflux pumps for insight on their potential role in chemoresistance of TNBC.

Download Publication
Learn More
Name(Required)